Benefits and Limitations
associated with Cancer-Scan program
A personal decision for the screening candidate
The decision to test with PanTum® Detect is a personal one for every individual.
The individual needs to be aware of the limitations and should weigh these against the benefits of annual screening with PanTum® Detect.
BENEFITS
PanTum® Detect has a high sensitivity of 97.5% (true positives) and specificity of 99% (true negatives) per IVD CE validation study and validated by the study on Indian population.
Available cancer diagnostic pathology and imaging solutions can be used more efficiently and effectively by pre testing with PanTum® Detect blood test.
Only those screened candidates who test positive with PanTum® Detect are exposed to follow up cancer pathology and imaging diagnostics.
Regular screening increases the chance of detecting a silently growing tumor in an early stage. When you annually test with PanTum® Detect and an suspicion of dangerous tumor development is found, the last negative result is no more than a year old.
LIMITATIONS
PanTum® Detect is not suitable for individuals with a compromised immune system which has an effect on circulating macrophage numbers.
No screening test provides a result that is 100% accurate or reliable.
Statistically, 1 in 100 candidates screened will receive a false positive result (they don't have the disease but test positive).
Statistically 2.5 in 100 candidates with disease will receive false negative result (they do have disease but test negative).
False results are a psychological strain for individuals that get screened with PanTum® Detect.
Connect with us for any queries
Connect with us for any queries
Useful Links
Support
Locate Us
© 2023. All rights reserved